Syndrome News and Research

RSS

Coronary stent implantation safe, feasible for infants or toddlers with ACS

Percutaneous coronary intervention (PCI) is not a generally accepted option for infants or toddlers with acute coronary syndrome. However, a new report published in the August issue of Catheterization and Cardiovascular Interventions, a journal of The Society for Cardiovascular Angiography and Interventions (SCAI), found coronary stent implantation to be a feasible and safe palliative option for children fifteen months and younger.

22 Aug 2011

NHLBI selects U-M Congenital Heart Center for clinical research

The University of Michigan Congenital Heart Center has been selected as a new Pediatric Heart Network core site for clinical research. Created and funded by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, the Pediatric Heart Network is a cooperative network of pediatric cardiovascular clinical research centers that conducts studies in children with congenital or acquired heart disease.

20 Aug 2011

Scientists report molecular structural basis for sex organ, head deformities

Scientists this month reported the molecular structural basis for severe head deformities and ambiguous sex organs in babies born with Antley-Bixler syndrome accompanied by an enzyme deficiency.

20 Aug 2011

First 5 LA awards Valley Presbyterian Hospital $500,000 to improve breastfeeding rates

First 5 LA announced today that it is awarding a grant of nearly $500,000 to Valley Presbyterian Hospital to improve the nutrition and health of the hospital's youngest patients by developing and maintaining policies and procedures to encourage increased breastfeeding among mothers of newborns.

19 Aug 2011

Conference to discuss latest research on gender disparities in cardiovascular disease

Heart disease has sometimes been considered a men's health issue, but the statistics prove otherwise. In the US alone, more than 42 million women live with the problem. Heart disease is responsible for more than one-third of deaths among American women each year, making it the number one killer of females older than 20.

19 Aug 2011

IRSF announces new Rett syndrome translational research awards

The International Rett Syndrome Foundation (IRSF) announced today that it is awarding over $650,000 to support eight cutting-edge projects that aim to accelerate translational research to develop treatments for Rett syndrome.

19 Aug 2011

People with metabolic abnormalities more likely to develop kidney disease

Metabolic syndrome comprises a group of medical disorders that increase people's risk of diabetes, heart disease, stroke, and premature death when they occur together. A patient is diagnosed with the syndrome when he or she exhibits three or more of the following characteristics: high blood pressure, high blood sugar, excess body fat in the waist/abdomen, low good cholesterol, and higher levels of fatty acids.

19 Aug 2011

Trans-Anal Minimally Invasive Surgery can remove large polyps with less pain, scarring

For the first time in the western United States, a surgical team lead by Elisabeth McLemore, MD, has used a novel operating platform to perform the scarless removal of rectal tumors. Called Trans-Anal Minimally Invasive Surgery (TAMIS), the technique allows surgeons to excise large polyps and masses that cannot be completely removed during a routine colonoscopy.

19 Aug 2011

Bill Clinton on being ‘vegan’

Former President Bill Clinton has revealed that his diet is turning plant-based and heart-healthy. He said he believes the vegan regimen is helping to reverse the damage to his heart and blood vessels caused by cardiovascular disease.

18 Aug 2011

Gene Security Network announces commercial launch of non-invasive prenatal test

Gene Security Network Inc. (GSN) today announced the commercial launch of its first non-invasive prenatal test powered by the company's proprietary bioinformatics technology, Parental Support™.

18 Aug 2011

NPS submits NDA CMC section to FDA for GATTEX

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today announced that it has submitted the chemistry, manufacturing and controls (CMC) section of its new drug application (NDA) for GATTEX® (teduglutide) to the U.S. Food and Drug Administration (FDA).

18 Aug 2011

New process may eliminate need for full genome sequencing for cancer patients

People at risk for a certain form of colon and other types of cancer may soon have a better chance at surviving or even avoiding the diseases, thanks to a new study done by the Intermountain Clinical Genetics Institute at LDS Hospital.

18 Aug 2011

Patients with diabetes, hypertension more likely to develop open-angle glaucoma

Many Americans suffer from diabetes and hypertension and, according to a study by researchers at the University of Michigan Kellogg Eye Center, these individuals may have an increased risk of developing open-angle glaucoma.

18 Aug 2011

PTSD impairs ability to recognize emotions from facial expressions

Facial expressions convey strong cues for someone's emotional state and the ability to interpret these cues is crucial in social interaction. This ability is known to be compromised in many psychiatric and neurological disorders, such as social anxiety or Korsakoff's syndrome.

17 Aug 2011

Moderate alcohol intake on a regular basis may increase risk of obesity

A paper from Spain provides an extensive review of the association between alcohol consumption and body weight. Based on the fact that the energy content in 1 gram of alcohol is 29 kJ or 7.1 kcal, excessive alcohol consumption can lead to weight gain.

17 Aug 2011

LYSOGENE launches the first gene therapy clinical trials in Sanfilippo disease

LYSOGENE announces the authorization by AFSSAPS (the French Agency for the Safety of Health Products) and by the Ethical Review Board of SAF-301, its leading intra-cerebral gene therapy phase I/II clinical trial aiming at treating Sanfilippo Type A Syndrome.

16 Aug 2011

FDA clears Resonance Health's MRI-Q System for cardiac T2* iron assessment

Resonance Health Ltd, a medical device company specializing in imaging core laboratory services has received FDA clearance to market its MRI-Q System.

16 Aug 2011

Customized computer models may identify patients at risk of Lynch syndrome

People who are at risk for a certain form of colon and other types of cancer may soon have a better chance at surviving or even avoiding the diseases, thanks to a new study done by the Intermountain Clinical Genetics Institute at LDS Hospital.

16 Aug 2011

Combination immunotherapy more effective for patients with Sezary Syndrome

A three-pronged immunotherapy approach nearly doubles five-year survival among patients with rare leukemic form of cutaneous T-cell lymphoma, reports a new study by dermatologists from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania.

16 Aug 2011

EOSS could predict risk of death in overweight, obese people

A new tool - the Edmonton obesity staging system (EOSS) - improves on current methods to predict the risk of death in overweight and obese people, according to a study in CMAJ.

16 Aug 2011